Plasma concentration of pyridostigmine during the antagonism of neuromuscular block.
Abstract
The plasma concentrations of pyridostigmine were measured in eight patients during the antagonism of non-depolarizing neuromuscular blockade. After the injection i.v. of pyridostigmine bromide 14.6 mg/70 kg, the concentration of the drug rapidly decreased between 2 and 7 min, and then declined more slowly. After 2 h, significant amounts of pyridostigmine were still present in the plasma of all subjects. In the eight patients studied, the initial half-life was 1.0 +/- 0.3 min and the terminal half-life was 46.4 +/- 6.5 min (mean +/- SEM). Total body clearance of pyridostigmine was 8.7 +/- 1.5 ml min-1 kg-1, and the total apparent volume of distribution was 536 +/- 80 ml kg-1. Possible explanations for the differences between these results and previous studies are considered.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | Plasma
|
scispacy | 1 | ||
| 해부 | neuromuscular
|
scispacy | 1 | ||
| 합병증 | non-depolarizing neuromuscular
|
scispacy | 1 | ||
| 약물 | pyridostigmine
|
C0034261
pyridostigmine
|
scispacy | 1 | |
| 약물 | pyridostigmine bromide
|
C0034262
pyridostigmine bromide
|
scispacy | 1 | |
| 약물 | mg/70
|
scispacy | 1 | ||
| 질환 | neuromuscular block
|
C0234119
Neuromuscular inhibition
|
scispacy | 1 | |
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Adult; Anesthesia, General; Atropine; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Pyridostigmine Bromide; Surgery, Plastic; Tubocurarine